Tharimmune

United Kingdom
Dorridge, England, United Kingdom, 07930

Company profile

Tharimmune company profile

Hillstream BioPharma is a development-stage company advancing improved therapies for patients with cancer via a unique QUATRAMERTM nanoparticle platform. This unique technology enables intranuclear and intracellular delivery of small molecules, peptides, genes, other macromolecules and biologics to the tumor cello, while significantly minimizing exposure to normal tissues.

Business identity

Contact email
[email protected]
Phone number
+1 302.743.2995
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2017-01-01, Year

Headquarters

Postal code
07930
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
7
Total equity funding
$618.5M
Last funding
Post IPO Equity / $55M / 2026-01-20
Last equity funding
Post IPO Equity / $55M
Investors
29
Lead investors
4
Founders
1
Articles
150
Exited on
2022-01-14

Founders and investors

Founders

Randy Milby

Lead investors

DRWGravitas CapitalLiberty City VenturesSDS Capital Group

Investors

ARK Investment ManagementClear StreetKrakenLiberty City VenturesThe TIE